SurModics to Webcast Third Quarter Fiscal Year 2011 Earnings Conference Call August 3

SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it will host a live webcast of its third quarter 2011 conference call on Wednesday, August 3, at 4:00 p.m. CT. The Company will issue an earnings news release after the market closes that afternoon.

Gary Maharaj, chief executive officer, and Phil Ankeny, senior vice president and chief financial officer, will recap the third quarter 2011 financial results and accomplishments. To access the webcast, go to the investor relations portion of the Company’s website at www.surmodics.com the day of the conference call and click on the webcast icon.

An audio replay will be available beginning at 7:00 p.m. CT on Wednesday, August 3, until 7:00 p.m. CT on Wednesday, August 10, and can be accessed by dialing 800-406-7325 and entering conference call ID passcode 4461515. In addition, the conference call audio will be archived on the Company’s website following the call.

About SurModics, Inc.

SurModics’ vision is to extend and improve the lives of patients through technology innovation. The Company partners with the world’s foremost medical device, pharmaceutical and life science companies to develop and commercialize innovative products that result in improved diagnosis and treatment for patients. Core offerings include: drug delivery technologies (coatings, microparticles, nanoparticles, and implants); surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. SurModics is headquartered in Eden Prairie, Minnesota and its SurModics Pharmaceuticals subsidiary is located in Birmingham, Alabama. For more information about the Company, visit www.surmodics.com. The content of SurModics’ website is not part of this release or part of any filings the Company makes with the SEC.